Show&Tell #4: Gastrointestinal cancers
- Watch this Show & Tell on Gastrointestinal cancers.
- Dr Andrew J. Wroe, Director of Proton Physics, and Dr Adeel Kaiser, Radiation Oncologist, will share c...
In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...
AMIT MAITY, MD, PhD Executive Vice-Chair Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia "Proton FLASH Radiation...
A randomized trial comparing proton therapy with transarterial chemoembolization (TACE) for hepatocellular carcinoma, reported a trend toward improved local...
A systematic review examined clinical outcomes and toxicities of proton therapy for gastrointestinal neoplasms. The findings include that proton therapy was...
Another study by the group from New York Proton Center (ProBeam) assessed the feasibility of FLASH RT using single-energy transmission PBS plans of 4.5 Gy × 15...
The improved dosimetry with proton therapy enables greater sparing of normal tissues...
This study by the Jacksonville group reported treatment outcomes of proton therapy for pancreatic cancer. 15 patients received 40.5 GyRBE in 18 fractions to the...